ES505678A0 - Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol - Google Patents
Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazolInfo
- Publication number
- ES505678A0 ES505678A0 ES505678A ES505678A ES505678A0 ES 505678 A0 ES505678 A0 ES 505678A0 ES 505678 A ES505678 A ES 505678A ES 505678 A ES505678 A ES 505678A ES 505678 A0 ES505678 A0 ES 505678A0
- Authority
- ES
- Spain
- Prior art keywords
- isotiazole
- aril
- derivative
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/189,435 US4346094A (en) | 1980-09-22 | 1980-09-22 | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8301225A1 ES8301225A1 (es) | 1982-12-01 |
| ES505678A0 true ES505678A0 (es) | 1982-12-01 |
Family
ID=22697314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES505678A Granted ES505678A0 (es) | 1980-09-22 | 1981-09-21 | Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4346094A (es) |
| EP (1) | EP0048615B1 (es) |
| JP (1) | JPS5785379A (es) |
| KR (1) | KR830007597A (es) |
| AR (1) | AR229103A1 (es) |
| AT (1) | ATE7657T1 (es) |
| AU (1) | AU7551681A (es) |
| CS (1) | CS228536B2 (es) |
| DD (1) | DD201790A5 (es) |
| DE (1) | DE3163900D1 (es) |
| DK (1) | DK417981A (es) |
| ES (1) | ES505678A0 (es) |
| FI (1) | FI812940L (es) |
| GB (1) | GB2084573B (es) |
| GR (1) | GR75046B (es) |
| IL (1) | IL63890A0 (es) |
| NO (1) | NO813208L (es) |
| PL (1) | PL130497B1 (es) |
| PT (1) | PT73711B (es) |
| RO (1) | RO82216A (es) |
| YU (1) | YU227181A (es) |
| ZA (1) | ZA816549B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431652A (en) * | 1980-12-29 | 1984-02-14 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4428956A (en) | 1980-12-29 | 1984-01-31 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4539328A (en) * | 1983-03-25 | 1985-09-03 | Fmc Corporation | Nematicidal isothiazole derivatives |
| US4620865A (en) * | 1983-11-07 | 1986-11-04 | Eli Lilly And Company | Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides |
| IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
| ZW21687A1 (en) * | 1986-12-12 | 1988-07-20 | Hoffmann La Roche | Triazine derivatives |
| DK0513379T3 (da) * | 1990-11-30 | 1996-09-30 | Teijin Ltd | 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne |
| US5294630A (en) * | 1992-07-07 | 1994-03-15 | Eli Lilly And Company | Treatment of inflammatory bowel disease |
| US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
| MY117352A (en) * | 1995-10-31 | 2004-06-30 | Ciba Sc Holding Ag | Oximesulfonic acid esters and the use thereof as latent sulfonic acids. |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| AU1520699A (en) | 1997-11-07 | 1999-05-31 | Johns Hopkins University, The | Methods for treatment of disorders of cardiac contractility |
| TW575792B (en) * | 1998-08-19 | 2004-02-11 | Ciba Sc Holding Ag | New unsaturated oxime derivatives and the use thereof as latent acids |
| SG78412A1 (en) | 1999-03-31 | 2001-02-20 | Ciba Sc Holding Ag | Oxime derivatives and the use thereof as latent acids |
| CA2474532A1 (en) | 2002-02-06 | 2003-08-14 | Peter Murer | Sulfonate derivatives and the use therof as latent acids |
| EP1783124A4 (en) * | 2004-08-27 | 2009-07-08 | Astellas Pharma Inc | 2-PHENYLTHIOPHENDERIVAT |
| US7820700B2 (en) * | 2004-08-27 | 2010-10-26 | Astellas Pharma Inc. | 2-phenylpyridine derivative |
| WO2007043457A1 (ja) | 2005-10-07 | 2007-04-19 | Astellas Pharma Inc. | トリアリールカルボン酸誘導体 |
| CN101389352B (zh) | 2006-02-24 | 2012-09-19 | 安斯泰来制药株式会社 | 治疗或预防消化道溃疡的药物 |
| GB2450975B (en) | 2007-07-12 | 2010-02-24 | Ciba Holding Inc | Yellow radiation curing inks |
| BRPI0913129A2 (pt) * | 2008-05-22 | 2016-01-05 | Bristol Myers Squibb Co | método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo |
| CN102333765B (zh) | 2009-02-27 | 2015-01-14 | 帝人制药株式会社 | 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法 |
| EP2414894B1 (en) | 2009-03-30 | 2014-02-12 | Basf Se | Uv-dose indicator films |
| KR101800054B1 (ko) | 2010-08-27 | 2017-11-21 | 데이진 화-마 가부시키가이샤 | 팔라듐 화합물을 사용한 커플링법에 의한 페닐 치환 복소 고리 유도체의 제조법 |
| WO2012101245A1 (en) | 2011-01-28 | 2012-08-02 | Basf Se | Polymerizable composition comprising an oxime sulfonate as thermal curing agent |
| HUE037813T2 (hu) * | 2013-03-29 | 2018-09-28 | Teijin Pharma Ltd | Pirazolszármazék |
| KR20170048422A (ko) | 2014-08-29 | 2017-05-08 | 바스프 에스이 | 옥심 술포네이트 유도체 |
| WO2016174043A1 (de) | 2015-04-29 | 2016-11-03 | Bsn Medical Gmbh | Mehrstufiges verfahren zur no-herstellung |
| WO2016174192A1 (de) | 2015-04-29 | 2016-11-03 | Bsn Medical Gmbh | Medizinische badevorrichtung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1178604A (en) * | 1966-03-21 | 1970-01-21 | American Cyanamid Co | Novel Pyridinium Salts and Methods for Preparing Same |
| US3464999A (en) * | 1967-07-27 | 1969-09-02 | R & L Molecular Research Ltd | Thiadiazolylisothiazoles |
| GB1180268A (en) * | 1967-09-26 | 1970-02-04 | Ici Ltd | Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives |
| GB1192701A (en) * | 1968-03-22 | 1970-05-20 | Ici Ltd | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same |
| US3681498A (en) * | 1970-10-19 | 1972-08-01 | American Cyanamid Co | Isothiazolyl pyridinium salts as hypoglycemic agents |
-
1980
- 1980-09-22 US US06/189,435 patent/US4346094A/en not_active Expired - Lifetime
-
1981
- 1981-09-19 PL PL1981233103A patent/PL130497B1/pl unknown
- 1981-09-20 IL IL63890A patent/IL63890A0/xx unknown
- 1981-09-21 GB GB8128465A patent/GB2084573B/en not_active Expired
- 1981-09-21 AT AT81304325T patent/ATE7657T1/de not_active IP Right Cessation
- 1981-09-21 EP EP81304325A patent/EP0048615B1/en not_active Expired
- 1981-09-21 AU AU75516/81A patent/AU7551681A/en not_active Abandoned
- 1981-09-21 FI FI812940A patent/FI812940L/fi not_active Application Discontinuation
- 1981-09-21 YU YU02271/81A patent/YU227181A/xx unknown
- 1981-09-21 RO RO81105346A patent/RO82216A/ro unknown
- 1981-09-21 DK DK417981A patent/DK417981A/da not_active Application Discontinuation
- 1981-09-21 AR AR286818A patent/AR229103A1/es active
- 1981-09-21 NO NO813208A patent/NO813208L/no unknown
- 1981-09-21 GR GR66108A patent/GR75046B/el unknown
- 1981-09-21 ES ES505678A patent/ES505678A0/es active Granted
- 1981-09-21 ZA ZA816549A patent/ZA816549B/xx unknown
- 1981-09-21 PT PT73711A patent/PT73711B/pt unknown
- 1981-09-21 DE DE8181304325T patent/DE3163900D1/de not_active Expired
- 1981-09-22 CS CS816978A patent/CS228536B2/cs unknown
- 1981-09-22 KR KR1019810003537A patent/KR830007597A/ko unknown
- 1981-09-22 JP JP56150483A patent/JPS5785379A/ja active Pending
- 1981-09-22 DD DD81233487A patent/DD201790A5/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT73711B (en) | 1982-12-20 |
| DD201790A5 (de) | 1983-08-10 |
| PL233103A1 (es) | 1982-12-20 |
| FI812940L (fi) | 1982-03-23 |
| IL63890A0 (en) | 1981-12-31 |
| US4346094A (en) | 1982-08-24 |
| DK417981A (da) | 1982-03-23 |
| PT73711A (en) | 1981-10-01 |
| EP0048615B1 (en) | 1984-05-30 |
| RO82216B (ro) | 1983-06-30 |
| ATE7657T1 (de) | 1984-06-15 |
| GB2084573A (en) | 1982-04-15 |
| RO82216A (ro) | 1983-07-07 |
| ES8301225A1 (es) | 1982-12-01 |
| AR229103A1 (es) | 1983-06-15 |
| GB2084573B (en) | 1984-09-12 |
| CS228536B2 (en) | 1984-05-14 |
| JPS5785379A (en) | 1982-05-28 |
| KR830007597A (ko) | 1983-11-04 |
| ZA816549B (en) | 1983-04-27 |
| NO813208L (no) | 1982-03-23 |
| DE3163900D1 (en) | 1984-07-05 |
| AU7551681A (en) | 1982-04-01 |
| YU227181A (en) | 1983-10-31 |
| GR75046B (es) | 1984-07-12 |
| PL130497B1 (en) | 1984-08-31 |
| EP0048615A1 (en) | 1982-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES505517A0 (es) | Un procedimiento para la preparacion de un derivado de n- arilbenzamida | |
| ES505950A0 (es) | Un procedimiento para la preparacion de un derivado de tia- zol | |
| ES504103A0 (es) | Un procedimiento para la preparacion de derivados de hidan- toina | |
| ES502906A0 (es) | Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina | |
| ES505678A0 (es) | Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol | |
| ES499079A0 (es) | Un procedimiento para la preparacion de un compuesto | |
| ES530714A0 (es) | Un procedimiento para la preparacion de un derivado de carbostirilo | |
| ES502994A0 (es) | Un procedimiento para la preparacion de derivados de pirazo-lopiridacina | |
| ES502792A0 (es) | Un procedimiento para la preparacion de derivados de imida- zol | |
| ES499077A0 (es) | Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos | |
| ES506141A0 (es) | Un procedimiento para la preparacion de piridin- y pira- cin-derivados | |
| ES499559A0 (es) | Un procedimiento para la preparacion de derivados de pirrol | |
| ES504323A0 (es) | Un procedimiento para la preparacion de un compuesto | |
| ES505518A0 (es) | Un procedimiento para la preparacion de un derivado de ben- zamida | |
| ES536982A0 (es) | Un procedimiento para la preparacion de un derivado de carbostirilo | |
| ES504764A0 (es) | Un procedimiento para la preparacion de un derivado 2-tiope-nem | |
| ES507755A0 (es) | Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida. | |
| ES504376A0 (es) | Un procedimiento para la preparacion de un derivado de fene-tilamina | |
| ES492230A0 (es) | Un procedimiento para la preparacion de nuevos derivados de carbostirilo | |
| ES505019A0 (es) | Un procedimiento para la preparacion de compuestos | |
| ES500911A0 (es) | Un procedimiento para la preparacion de derivados de ergoli-na | |
| ES501232A0 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
| ES498145A0 (es) | Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas | |
| ES499572A0 (es) | Un procedimiento para la preparacion de nuevas guanilamidi- nas | |
| ES501534A0 (es) | Un procedimiento para la preparacion de derivado de bis-hidroxibencilo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20010201 |